Erectile Dysfunction Drugs Market Size to Reach USD 6,162.9 Million by 2030 at a CAGR of 6.80% – Market Research Future (MRFR) Report


Future of Market Research

Erectile Dysfunction Drugs Market Trends and Outlook by Drugs (Viagra (sildenafil citrate), Cialis (Tadalafil), Staxyn/Levitra (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Cream of alprostadil)), End-User (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa), Competitive Market Growth, Size, Share and Forecast to 2030

New York, U.S., Nov. 22, 2022 (GLOBE NEWSWIRE) — Erectile Dysfunction Drugs Market Overview

According to a comprehensive research report by Market Research Future (MRFR), “Erectile Dysfunction Drugs Market Information by drugs, end user and region – Forecast to 2030“The market is expected to reach USD 6,162.9 million by 2030 at a CAGR of 6.80% during the forecast period 2022-2030.

Market scope:

The inability to get and maintain a firm erection during sexual engagement is known as erectile dysfunction. Having erection problems is usually not a cause for concern. However, if erectile dysfunction persists over time, it can lead to stress, low self-esteem, and marital problems. The inability to get or keep an erection can be a sign of more serious underlying medical conditions and increase the risk of cardiovascular disease. There are various medications in the market that can help maintain erection during sexual activity to treat such situations. The demand for these drugs is increasing due to changing lifestyles and high stress levels.

Diabetes, obesity and cardiovascular diseases are on the rise due to the increasing adoption of an unhealthy lifestyle, which in turn causes problems such as erectile dysfunction as people age. The current lifestyles of young people are particularly stressful in many emerging countries, which has led to an increase in the consumption of fast food and ready-to-eat foods, as well as alcohol and smoking. These variables compromise general health and physical fitness, which increases the risk of erectile dysfunction. Additionally, the number of ED patients is increasing along with the growing elderly population, which continues to be a major driver of the global erectile dysfunction drugs market during the projection period.

Get Free Sample PDF Brochure @

Report Scope:

Report attribute


Market size in 2030

$6162.9 million



base year


Forecast period


Historical data


Forecast units

Value (USD million)

Report cover

Revenue forecasts, competitive landscape, growth factors and trends

Segments Covered

By drugs and end user

Geographical areas covered

North America, Europe, Asia-Pacific and Rest of the World (RoW)

Key Market Drivers

Increase in the geriatric population

Increase in the number of cases of erectile dysfunction

Erectile Dysfunction Drugs Market Competitive analysis:

Some of the most prominent vendors in the erectile dysfunction drug industry are

  • Meda Pharmaceuticals Inc.

  • Pfizer Inc.

  • Apricus Biosciences Inc.

  • Teva Pharmaceutical Industries Ltd

  • Vivu Inc.

  • SK Chemicals Co.Ltd.

  • Bayer AG

  • Dong-A Pharmaceutical Co. Ltd.

  • Cristalia Produtos Quimicos Farmaceuticos Ltd.

  • Eli Lilly and company

Erectile Dysfunction Drugs Market Dynamic

Market factors

Various mental health issues along with the stress of hectic lifestyles have a serious impact on a person’s health and can cause erectile dysfunction. Psychological and physical problems can also lead to erectile dysfunction. Sedentary lifestyle, excessive smoking and alcohol consumption are also some important aggravating factors. The in-depth UK Health Center study reveals that around 60% of the country’s male population smokes the whole pack of cigarettes in a single day, which increases the risk of developing erectile dysfunction.

The steady progress of the erectile dysfunction industry is further in response to the soaring patient knowledge about the disease and the increasing level of education globally. Rising geriatric patient population and increase in many lifestyle disorders are also driving the market growth. Strong brand loyalty combined with the growing popularity of different brands such as Levitra/Staxyn, Cialis and Viagra, further adds to market value.

The global industry is extremely consolidated, teeming with diverse companies actively seeking ways to strengthen their positions in the face of fierce competition. Generics will drive business growth while mergers, collaborations, acquisitions, and post-patent expiration activities will increase the competitive quotient in the years to come.

Erectile Dysfunction Drugs Market Constraints

Erectile dysfunction drugs are primarily sold in developed and emerging economies; but low- and middle-income countries account for a smaller portion of their sales. This is mainly due to people’s lack of understanding of these types of treatments, their limited purchasing power and their reluctance to integrate them into their daily lives. The low growth of the market is partly attributed to the negative side effects of these drugs including headaches, upset stomach, flushing, nasal congestion, visual problems, dizziness, diarrhea and rashes .

COVID-19 analysis

COVID-19 is expected to have a brief and minimal impact on industry growth. The impact of the pandemic on the market varies by country depending on the quality of local health systems and the measures taken to combat it. Urological interventions were not considered urgent throughout the outbreak. In order to reduce the danger, all elective and ambulatory interventional procedures have been reduced or stopped. Specialized dialysis centers and associated services were also closed during this period, which negatively impacted the company’s ability to grow. Industry players have also observed a significant drop in sales in 2020.

Browse the in-depth market research report (80 pages) at Erectile dysfunction drugs:

On the bright side, the supply chains of the majority of healthcare organizations will operate effectively and efficiently over the projected period, as lockdown limitations are gradually eased in most countries. As a result, the global market is predicted to grow significantly over the next few years. For example, the majority of elective procedures were restarted between the fourth quarter of 2020 and the first quarter of 2021, as the regulations imposed by the governments of various countries were relaxed. This has increased the number of patients being treated in hospitals and dialysis centers, which has helped to partly stabilize the global market.

Erectile Dysfunction Drugs Market Segmentation

By drug

The main drugs sold to treat erectile dysfunction are cialis (tadalafil), zydena (udenafil), stendra/spedra (avanafil), viagra (sildenafil citrate), vitaros (alprostadil cream), staxyn/ levitra (vardenafil) and others.

Per end user

The main end users within the global industry are retail pharmacies, hospital pharmacies as well as online pharmacies.

Buy now:

Erectile Dysfunction Drugs Market Regional analysis

The Americas ranks first in the global erectile dysfunction drugs market with the United States ranking first in the region. The burgeoning base of older patients affected by erectile dysfunction is helping the US market, as the condition largely affects men over the age of 40. The availability of different effective erectile dysfunction drugs, especially on online as well as over-the-counter channels, could have a huge effect. also in the regional market.

Share your queries @

The fastest progress will be made by the APAC market in the coming years, due to the rapid growth of the elderly population susceptible to erectile dysfunction coupled with the boom in generic drug sales. Government led initiatives and reforms as well as public awareness programs in many developing economies such as Japan, Singapore, China and India are increasing the rate of the growth trajectory. Rapid economic growth, improved medical infrastructure and expanding target population are other encouraging factors. New combinations of molecules coupled with the increasing use of drug delivery techniques such as lozenges as well as creams with improved efficacy and performance could present exciting opportunities for leading ED drug developers to the future.

Discover more research reports on The health industryby Market Research Future:

Menopause Treatment Market By treatment (hormonal therapy (estrogen, progesterone and combination), non-hormonal therapy (antidepressants), distribution channel (hospital pharmacies, retail pharmacies, online shops) – Forecast to 2027

sexual wellness market Size and Trend Analysis by Product (Sex Toys, Condoms, Contraceptives, Sexual Enhancement Supplements, Lubricants, Ointments), Distribution Channels (Pharmacies, Specialty Stores, Supermarkets, Online Platforms) – Forecast to 2030

menstrual cup market Research report: information by material (silicone, thermoplastic isomer, rubber and latex), by size (small and large), by ease of use (reusable and disposable), by shape (round, hollow, pointed and flat), by type (vaginal cut and cervical cut), by distribution channel (hospital pharmacy, retail pharmacy, online pharmacy and others) and by region (North America, Europe, Asia-Pacific and rest of the world) – Forecasts until 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that prides itself on its services, offering comprehensive and accurate analysis with respect to various markets and consumers around the world. Market Research Future has the distinct objective of providing clients with top quality research and granular research. Our market research by products, services, technologies, applications, end users and market players for global, regional and country market segments enables our clients to see more, know more and do more , which helps answer your most important questions. questions.

Follow us: LinkedIn | Twitter

CONTACT: Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: [email protected] Website:

Comments are closed.